Literature DB >> 16622591

A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis.

Pinar Borman1, Guneş Gur Toy, Seçil Babaoğlu, Hatice Bodur, Deniz Ciliz, Nuran Alli.   

Abstract

Both rheumatoid arthritis (RA) and psoriatic arthritis (PsA) have a negative impact on patients' quality of life (QOL). The aim of this study was to compare QOL and life satisfaction in patients with RA and PsA. Forty patients with PsA, 40 patients with RA, and 40 healthy control subjects were included in the study. Demographic data and clinical characteristics including age, sex, disease duration, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), peripheral pain assessed by visual analog scale (VAS) and Larsen scores of hand X-rays were recorded. Nottingham Health Profile (NHP) was used to evaluate QOL, and Life satisfaction index (LSI) was used to measure psychological well-being in both groups. The demographic data of the subjects were similar between the groups. The scores of all NHP subscales were significantly higher and the scores of LSI were significantly lower in PsA and RA patients than in control subjects. The inflammation markers including ESR, CRP, pain by VAS and Larsen scores were found to be significantly higher in RA patients. The scores of LSI were similar between the groups. Although the scores of physical domains of NHP (pain and physical disability) were statistically higher in RA patients (p<0.05), the scores of psychosocial subgroups of NHP were similar between RA and PsA patients (p>0.05). Both PsA and RA patients had disturbed QOL and decreased life satisfaction. In conclusion, peripheral joint damage, inflammation, and physical disability are significantly greater in RA but psychosocial reflection of QOL and life satisfaction are the same for both groups which can be explained by the additional impact of skin disease in patients with PsA.

Entities:  

Mesh:

Year:  2006        PMID: 16622591     DOI: 10.1007/s10067-006-0298-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 2.  The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.

Authors:  John De Korte; Femke M C Mombers; Mirjam A G Sprangers; Jan D Bos
Journal:  Arch Dermatol       Date:  2002-09

3.  Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

Authors:  J A Husted; D D Gladman; V T Farewell; R J Cook
Journal:  Arthritis Rheum       Date:  2001-04

Review 4.  The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials.

Authors:  Z Ortiz; B Shea; M Garcia Dieguez; M Boers; P Tugwell; A Boonen; G Wells
Journal:  J Rheumatol       Date:  1999-01       Impact factor: 4.666

5.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

6.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

7.  Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

Authors:  K B Sokoll; P S Helliwell
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

8.  Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

Authors:  Hugh Zachariae; Robert Zachariae; Kirsti Blomqvist; Steingrimur Davidsson; Lars Molin; Cato Mørk; Bardur Sigurgeirsson
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

9.  Functional disability and quality of life in patients with ankylosing spondylitis.

Authors:  Elif E Bostan; Pinar Borman; Hatice Bodur; Nurdan Barça
Journal:  Rheumatol Int       Date:  2002-10-30       Impact factor: 2.631

10.  Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

Authors:  J Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F Rosen; Frank Behrens; Peter Jones; Jürgen Wollenhaupt; Franziska G Falk; Philip Mease
Journal:  Arthritis Rheum       Date:  2004-06
View more
  24 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

Review 2.  Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

Authors:  William J Taylor
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

3.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

4.  Psoriatic Arthritis Quality of Life questionnaire: translation, cultural adaptation and validation into Portuguese language.

Authors:  Anabela Barcelos; Catarina Ambrósio; J A Pereira da Silva; Stephen McKenna; Jeanette Wilburn; Pedro Lopes Ferreira
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

5.  Lay Perspectives of Quality of Life in Rheumatoid Arthritis Patients: The Relevance of Autonomy and Psychological Distress.

Authors:  Isabel Santos; Natália Duarte; Oscar Ribeiro; Pedro Cantista; Carlos Vasconcelos
Journal:  Community Ment Health J       Date:  2019-03-29

6.  The Burden of Rheumatic Diseases: An Analysis of an Italian Administrative Database.

Authors:  Sergio Iannazzo; Gianluca Furneri; Federica Demma; Chiara Distante; Simone Parisi; Veronica Berti; Enrico Fusaro
Journal:  Rheumatol Ther       Date:  2016-05-26

7.  Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept.

Authors:  Andrea Picchianti-Diamanti; Valentina Germano; Claudia Ferlito; Alberto Migliore; Raffaele D'Amelio; Bruno Laganà
Journal:  Qual Life Res       Date:  2010-04-06       Impact factor: 4.147

8.  Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data.

Authors:  Majed Khraishi; Jelena Ivanovic; Yvonne Zhang; Brad Millson; Marie-Josee Brabant; Katia Charland; John Woolcott; Heather Jones
Journal:  Clin Rheumatol       Date:  2018-05-16       Impact factor: 2.980

Review 9.  Psoriatic arthritis epidemiology.

Authors:  Arathi R Setty; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

10.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.